TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Program Project Payline Is 125; Budget Cuts Will Allow NCI To Fund 49 Competing P01s February 28, 1992
TCL Archive Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression November 30, 2012
